Vanguard Global Advisers’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$75.8K Buy
15,461
+183
+1% +$1.07K ﹤0.01% 2899
2026
Q2
$73.6K Hold
15,278
– – ﹤0.01% 2927
2026
Q1
$94.1K Buy
+15,278
New +$127K ﹤0.01% 2752

Other funds holding RXST

Vanguard Global Advisers's RXST Position: Q3 2026 in Review

Vanguard Global Advisers increased its RxSight (RXST) stake by 1.2% in Q3 2026, buying an estimated $1.07K and bringing the position to 15,461 shares worth $75.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2899.

Vanguard Global Advisers first reported a position in RXST in Q1 2026 and has held it in 3 quarters since. The position peaked at $94.1K in Q1 2026. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Vanguard Global Advisers held 15,461 shares of RxSight worth $75.8K as of Q3 2026.
  • Vanguard Global Advisers bought 183 RxSight shares in Q3 2026, an estimated $1.07K.
  • RxSight made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2899 holding.
  • Vanguard Global Advisers first reported a position in RxSight in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's RxSight position peaked at $94.1K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.